Those graphs have been published for more than 3 years and nobody so far wants to partner. Of course, any compelling clinical data could change that but don't expect anyone to jump on any time soon. Big guys have become very cautious and want extraordinary results. Complete responses, as seen here and at IMU, aren't enough anymore. Unfortunately.
If the above was wrong CHM would have been inundated with $$$ and won't be in this dire straight situation.
That's the reality. We all, me including, hoped we would invest into something spectacular. No, we haven't. Even the GBM CAR-T suddenly isn't attractive anymore.
CHM Price at posting:
0.9¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)